...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators
【24h】

Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators

机译:一系列(1-烷基-3-甲基-1H-吡唑-5-基)-2-(5-芳基-2H-四唑-2-基)乙酰胺作为新型Girk1 / 2钾通道的发现,合成和表征 激活者

获取原文
获取原文并翻译 | 示例
           

摘要

The present study describes the discovery and characterization of a series of 5-aryl-2H-tetrazol-3-ylacetamides as G protein-gated inwardly-rectifying potassium (GIRK) channels activators. Working from an initial hit discovered during a high-throughput screening campaign, we identified a tetrazole scaffold that shifts away from the previously reported urea-based scaffolds while remaining effective GIRK1/2 channel activators. In addition, we evaluated the compounds in Tier 1 DMPK assays and have identified a (3-methyl-1H-pyrazol-1-yl)tetrahydrothiophene-1,1-dioxide head group that imparts interesting and unexpected microsomal stability compared to previously-reported pyrazole head groups.
机译:本研究描述了一系列5-芳基-2H-四唑-3-酰基乙酰胺的发现和表征,如G蛋白门控内整流钾(GIRK)通道活化剂。 在高吞吐量筛选活动期间发现的初始击中,我们确定了四唑脚手架,其远离先前报告的基于尿素的支架,同时剩下有效的GIRK1 / 2通道活化剂。 此外,我们评估了第1层DMPK测定中的化合物,并已鉴定(3-甲基-1H-吡唑-1-基)四氢噻吩-1,1-二氧化乙烯的头部,其与先前报道的相比赋予了有趣和意外的微粒体稳定性 吡唑头组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号